International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 1 , Pages 23-28 , 1 September 2009

Genitourinary Toxicity After High-Dose-Rate (HDR) Brachytherapy Combined With Hypofractionated External Beam Radiotherapy for Localized Prostate Cancer: An Analysis to Determine the Correlation Between Dose–Volume Histogram Parameters in HDR Brachytherapy and Severity of Toxicity

  • Hiromichi Ishiyama, M.D.

      Affiliations

    • Department of Radiology, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan
    • Corresponding Author InformationReprint requests to: Hiromichi Ishiyama, M.D., Department of Radiology, Kitasato University School of Medicine, 1-15-1 Kitasato, Sagamihara, Japan. Tel: (+81) 778-8453; Fax: (+81) 778-9436
    • ,
  • Masashi Kitano, M.D.

      Affiliations

    • Department of Radiology, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan
    • ,
  • Takefumi Satoh, M.D.

      Affiliations

    • Department of Urology, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan
    • ,
  • Shouko Kotani, M.D.

      Affiliations

    • Department of Radiology, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan
    • ,
  • Mineko Uemae, R.T.

      Affiliations

    • Division of Radiation Oncology, Kitasato University Hospital, Kitasato, Sagamihara, Kanagawa, Japan
    • ,
  • Kazumasa Matsumoto, M.D.

      Affiliations

    • Department of Urology, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan
    • ,
  • Hiroshi Okusa, M.D.

      Affiliations

    • Department of Urology, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan
    • ,
  • Ken-ichi Tabata, M.D.

      Affiliations

    • Department of Urology, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan
    • ,
  • Shiro Baba, M.D.

      Affiliations

    • Department of Urology, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan
    • ,
  • Kazushige Hayakawa, M.D.

      Affiliations

    • Department of Radiology, Kitasato University School of Medicine, Kitasato, Sagamihara, Kanagawa, Japan

Received 18 June 2008 ,Revised 4 September 2008 ,Accepted 2 November 2008.

References 

  1. Pollack A, Zagars GK, Starkshall G, et al. Prostate cancer radiation dose response: Results of the M.D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys. 2002;53:1097–1105
  2. Hanks GE, Hanlon AL, Schultheiss TE, et al. Dose escalation with 3D conformal treatment: Five year outcomes, treatment optimization, and future directions. Int J Radiat Oncol Biol Phys. 1998;41:501–510
  3. Hanks GE, Schultheiss TE, Hanlon AL, et al. Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study. Int J Radiat Oncol Biol Phys. 1997;37:543–550
  4. Nag S, Beyer D, Friedland J, et al. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys. 1999;44:789–799
  5. Egawa S, Shimura S, Irie A, et al. Toxicity and health-related quality of life during and after high dose rate brachytherapy followed by external beam radiotherapy for prostate cancer. Jpn J Clin Oncol. 2001;31:541–547
  6. Satoh T, Kitano M, Fujita T, et al. High-dose rate iridium-192 brachytherapy boost to external beam radiation therapy for prostate cancer in Japanese men. Jpn J Endourol ESWL. 2005;18:273–277
  7. Akimoto T, Ito K, Saitoh J, et al. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys. 2005;63:463–471
  8. Akimoto T, Katoh H, Noda S, et al. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Int J Radiat Oncol Biol Phys. 2005;63:472–478
  9. Cassio A, Pellizzon A, Salvajoli JV, et al. Late urinary toxicity with high dose prostate brachytherapy as a boost to conventional external beam radiation therapy for local and locally advanced prostate cancer. J Urol. 2004;171:1105–1108
  10. Tharp M, Bennett R, Burns J, et al. Prostate high dose rate brachytherapy in a free-standing cancer center setting. Am J Clin Oncol. 2007;30:520–525
  11. Chen Y, Chuand C, Hsieh M, et al. High-dose-rate brachytherapy plus external beam radiotherapy for T1 to T3 prostate cancer: An experience in Taiwan. Urology. 2007;70:101–105
  12. Duchesne GM, Williams SG, Das R, et al. Patterns of toxicity following high-dose-rate brachytherapy boost for prostate cancer: Mature prospective phase I/II study results. Radiother Oncol. 2007;84:128–134
  13. Hoskin PJ, Motohashi K, Bownes P, et al. High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: Initial results of a randomized phase three trial. Radiother Oncol. 2007;84:114–120
  14. Chiand PH, Fang FM, Jong WC, et al. High-dose rate iridium-192 brachytherapy and external beam radiation therapy for prostate cancer with or without androgen ablation. Int J Urol. 2004;11:152–158
  15. Phan TP, Syed AMN, Puthawala A, et al. High dose rate brachytherapy as a boost for the treatment of localized prostate cancer. J Urol. 2007;177:123–127
  16. Vargas CE, Martinez AA, Boike TP, et al. High-dose irradiation for prostate cancer via a high-dose-rate brachytherapy boost: Results of a phase I to II study. Int J Radiat Oncol Biol Phys. 2006;66:416–423
  17. Demanes DJ, Rodriguez RR, Schour L, et al. High-dose-rate intensity-modulated brachytherapy with external beam radiotherapy for prostate cancer: California endocurietherapy's 10-year results. Int J Radiat Oncol Biol Phys. 2005;61:1306–1316
  18. Pinkawa M, Fischedick K, Treusacher P, et al. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer—A phase II study. Radiother Oncol. 2006;78:41–46
  19. Galalae RM, Martinez A, Nuernberg N, et al. Hypofractionated conformal HDR brachytherapy in hormone naïve men with localized prostate cancer: Is escalation to very high biologically equivalent dose beneficial in all prognostic risk groups?. Strahlenther Onkol. 2006;182:135–141
  20. Aström L, Pedersen D, Mercke C, et al. Long-term outcome of high dose rate brachytherapy in radiotherapy of localized prostate cancer. Radiother Oncol. 2005;74:157–161
  21. Jo Y, Hiratsuka J, Fujii T, et al. High-dose-rate iridium-192 afterloading therapy combined with external beam radiotherapy for T1c-T3bN0M0 prostate cancer. Urology. 2004;64:556–560
  22. Stevens MJ, Stricker PD, Saalfeld J, et al. Treatment of localized prostate cancer using a combination of high dose rate iridium-192 brachytherapy and external beam irradiation: Initial Australian experience. Australas Radiol. 2003;47:152–160
  23. Yoshioka Y, Nose T, Yoshida K, et al. High-dose-rate brachytherapy as monotherapy for localized prostate cancer: A retrospective analysis with special focus on tolerance and chronic toxicity. Int J Radiat Oncol Biol Phys. 2003;56:213–220
  24. Martinez A. Gonzalez, J, Spencer W. Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factors. J Urol. 2003;169:974–980
  25. Duchesne G, Das R, Toye W, et al. Dose distribution and toxicity after high dose rate brachytherapy for prostate cancer: Influence of V150 and V200 parameters. Australas Radiol. 2002;46:384–389
  26. Deger S, Boehmer D, Roigas J, et al. High dose rate (HDR) brachytherapy with conformal radiation therapy for localized prostate cancer. Eur Urol. 2005;47:441–448
  27. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the RTOG and EORTC. Int J Radiat Oncol Biol Phys. 1995;31:1341–1346

 This study was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare of Japan.

 Conflict of interest: none.

PII: S0360-3016(08)03729-2

doi: 10.1016/j.ijrobp.2008.11.006

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 1 , Pages 23-28 , 1 September 2009

Article Tools

* Image Usage & Resolution